Researchers used the Parsortix ® system to isolate and harvest CTCs from 30 patients with EGFR-mutated NSCLC that were undergoing treatment with osimertinib (TAGRISSO: AstraZeneca). Osimertinib is an ...

More than 400 million people currently suffer from some type of diabetes, a figure that represents 1 in 11 adults worldwide ...

Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...

AstraZeneca’s presence in South Africa has become a driving force in global health research, contributing significantly to respiratory, cardiovascular, and oncology therapeutic areas. The ...

Having got off to a strong start to the year the UK economy is expected to slow in the second half of this year. In Q1 we saw the economy achieve growth of 0.6%, before slowing modestly to 0.5% in Q2, ...

The global oral solid dosage pharmaceutical formulation market is poised for remarkable expansion, with projections indicating a growth from USD 629,582.6 million in 2024 to USD 895,636.0 million by ...

More than half of Singaporeans (64%) said they are managing diabetes, but 60% of these individuals have high blood glucose ...

AstraZeneca plans to hire over 800 in Singapore for engineering, quality, technical services, and supply chain roles at its ...

The global market for peptide therapies is projected to grow at an outstanding compound annual growth rate (CAGR) of 10.8% ...

Respiratory Inhaler Devices MarketThe global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching ...

Q3 2024 Earnings Call Transcript November 5, 2024 Operator: Good morning, everyone, and welcome to the Cellectis Third ...

Pharmaceutical giant AstraZeneca said Thursday that the head of its China operations had been detained, after reports the ...